MONA LILLY SHIRAZI WELZ
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAKEWOOD, CO NPI 1124683602
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CO Acerta Pharma LLC All categories
General Payments — all program years on this page
$526.39
- Category: General Payments
- Program years: PY2021–2023
- Record count: 28
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $121.99 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $106.72 | 6 |
| Education | $15.27 | 1 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $72.28 | 4 |
| Blueprint Medicines Corporation | $18.74 | 1 |
| Genentech USA, Inc. | $15.70 | 1 |
| PFIZER INC. | $15.27 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1015737277 | AstraZeneca Pharmaceuticals LP | $15.87 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015909873 | AstraZeneca Pharmaceuticals LP | $14.41 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015929935 | AstraZeneca Pharmaceuticals LP | $19.00 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015980043 | AstraZeneca Pharmaceuticals LP | $23.00 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1040685859 | Genentech USA, Inc. | $15.70 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1049591779 | PFIZER INC. | $15.27 | 02/02/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1051276695 | Blueprint Medicines Corporation | $18.74 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.